Global Oligonucleotide Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Oligonucleotide market size was valued at USD 1290.3 million in 2023 and is forecast to a readjusted size of USD 2461.4 million by 2030 with a CAGR of 9.7% during review period.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
The Global Info Research report includes an overview of the development of the Oligonucleotide industry chain, the market status of Gene Chip (DNA, RNA), Electrophoresis (DNA, RNA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oligonucleotide.
Regionally, the report analyzes the Oligonucleotide markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oligonucleotide market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oligonucleotide market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oligonucleotide industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., DNA, RNA).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oligonucleotide market.
Regional Analysis: The report involves examining the Oligonucleotide market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oligonucleotide market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oligonucleotide:
Company Analysis: Report covers individual Oligonucleotide manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oligonucleotide This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Gene Chip, Electrophoresis).
Technology Analysis: Report covers specific technologies relevant to Oligonucleotide. It assesses the current state, advancements, and potential future developments in Oligonucleotide areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oligonucleotide market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oligonucleotide market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
DNA
RNA
Market segment by Application
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
Major players covered
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
Oligo Factory
Danaher
Thermo Fisher Scientific
GE
Merck
Eurofins Scientific
Agilent
SUMITOMO CHEMICAL
Bachem
Sylentis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oligonucleotide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oligonucleotide, with price, sales, revenue and global market share of Oligonucleotide from 2019 to 2024.
Chapter 3, the Oligonucleotide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oligonucleotide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oligonucleotide market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oligonucleotide.
Chapter 14 and 15, to describe Oligonucleotide sales channel, distributors, customers, research findings and conclusion.